Phase Bio Pharmaceuticals Inc announced it raised $21 Million in an amended filing from an offering of $42 Million

Jul 21, 2015•about 10 years ago

Amount Raised

$21 Million

PennsylvaniaBiotechnology

Company Information

Company

PhaseBio Pharmaceuticals Inc

Location

Pennsylvania, United States

About

PhaseBio is a clinical-stage biopharmaceutical company developing drugs for cardiovascular diseases, endocrine and metabolic disorders.

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech